Toxoplasmosis in Cats: Neurological Symptoms, Cytology, Pregnancy Risks, and Veterinary Care

Introduction

Toxoplasmosis is a globally distributed protozoan infection caused by the obligate intracellular apicomplexan parasite Toxoplasma gondii. Felids, particularly domestic cats (Felis catus), serve as the definitive host in which the parasite completes its sexual cycle and sheds environmentally resistant oocysts. In cats, infection is typically subclinical, but acute or recrudescent disease can produce severe systemic signs, including prominent neurological manifestations. This article provides a detailed clinical reference for veterinary practitioners covering the etiology, transmission, pathogenesis, diagnostic cytology, pregnancy risks, and therapeutic management of feline toxoplasmosis. Special attention is given to neurological symptoms, cytological interpretation, and clinical decision-making for breeding queens.

Etiology and Life Cycle

Toxoplasma gondii exists in three infectious stages: tachyzoites (rapidly dividing), bradyzoites (slowly dividing within tissue cysts), and sporozoites (within sporulated oocysts). The life cycle is heteroxenous. Sexual reproduction occurs exclusively in the intestinal epithelium of felids, leading to the production of unsporulated oocysts shed in feces. These oocysts sporulate in the environment within 1 to 5 days under appropriate temperature and humidity, becoming infective. Ingestion of sporulated oocysts by intermediate hosts (including cats themselves) or ingestion of tissue cysts in raw or undercooked meat are the primary routes of infection [1].

After ingestion, sporozoites or bradyzoites convert to tachyzoites, which disseminate hematogenously and invade nucleated cells throughout the body. Tachyzoites replicate intracellularly, rupturing cells and causing focal necrosis. Immune pressure drives conversion to bradyzoites, which encyst predominantly in skeletal muscle, myocardium, and central nervous tissue. Tissue cysts persist for the life of the host and can reactivate during immunosuppression.

Transmission in Cats

Cats become infected through three principal mechanisms:

1. Predation and raw meat ingestion: Hunting or consumption of raw meat containing tissue cysts is the most efficient route. A single tissue cyst can initiate infection.

2. Oocyst ingestion: Cats may ingest sporulated oocysts from contaminated soil, litter, or fomites. This route produces a longer prepatent period compared to tissue cyst ingestion.

3. Transplacental transmission: Although less common in cats than in some intermediate hosts, congenital transmission can occur if a queen is infected during gestation. This is a critical consideration for breeding catteries.

Indoor-only cats that are not fed raw diets have a substantially lower risk of infection, but oocysts can be tracked indoors on shoes or via contaminated supplies. The prepatent period (time from infection to oocyst shedding) ranges from 3 to 10 days after tissue cyst ingestion and 19 to 48 days after oocyst ingestion. Oocyst shedding typically lasts 1 to 3 weeks and is most intense during primary infection. Re-shedding after reinfection is rare but documented in immunosuppressed animals.

Pathogenesis and Host Response

Following oral infection, tachyzoites invade enterocytes, then disseminate via lymphatics and blood to reach the liver, lungs, lymph nodes, and central nervous system (CNS). The host mounting a robust cell-mediated immune response involving interferon-gamma (IFN-gamma) and cytotoxic T lymphocytes controls tachyzoite proliferation. In most immunocompetent cats, infection is self-limiting and subclinical. However, in kittens, geriatric cats, or those with concurrent retroviral infections (e.g., Feline Leukemia Virus progressive infection or Feline Coronavirus associated feline infectious peritonitis), rapid tachyzoite multiplication can cause widespread necrosis [2].

In the CNS, bradyzoite reactivation leads to focal or multifocal granulomatous encephalomyelitis, often accompanied by necrosis and perivascular cuffing. Lesions are most common in the brainstem, cerebrum, and cerebellum. Ocular involvement frequently accompanies CNS disease, manifesting as panuveitis or retinochoroiditis. Pulmonary and hepatic involvement can occur in acute systemic toxoplasmosis.

Clinical Signs

Neurological Symptoms

Neurological signs are among the most striking presentations of symptomatic toxoplasmosis in cats. They result from granulomatous encephalomyelitis and may include:

• Altered mentation (depression, stupor, head pressing)
• Seizures (generalized or partial motor)
• Circling, ataxia, and vestibular signs (head tilt, nystagmus)
• Cranial nerve deficits (anisocoria, facial nerve paralysis)
• Spinal cord signs (paresis, ataxia, proprioceptive deficits)
• Behavioral changes (aggression, lethargy, disorientation)

The onset can be acute or gradual. Fever may be present but is not universal. Neurological deficits may improve with treatment if diagnosed early, but residual sequelae are common.

Ocular Signs

Ocular toxoplasmosis presents as unilateral or bilateral uveitis, often granulomatous. Anterior uveitis (aqueous flare, hypopyon, keratic precipitates) and posterior uveitis (retinochoroiditis, retinal detachment) can occur. Focal retinal lesions appear as white or yellow infiltrates. Chronic infection may lead to glaucoma, lens luxation, or blindness.

Systemic Signs

Non-neurological signs include lethargy, anorexia, fever, dyspnea (due to pneumonia), icterus (hepatic necrosis), pancreatitis, and myositis. Cats with pulmonary toxoplasmosis may present with tachypnea and crackles. Myocardial involvement can cause arrhythmias or heart failure.

Diagnosis

Diagnosis relies on a combination of serology, molecular testing, cytology, histopathology, and imaging. Given that many cats are seropositive without active disease, interpretation of serological results must consider IgM and IgG kinetics.

Serology

Serological detection of anti-Toxoplasma antibodies is the most common screening tool. Commercial enzyme-linked immunosorbent assays (ELISA) and indirect immunofluorescence assays (IFA) are available. For a detailed discussion of ELISA methodology, refer to the article on Enzyme-Linked Immunosorbent Assay (ELISA) for Feline Leukemia Virus. In toxoplasmosis, the following patterns aid interpretation:

IgM can persist for months, so a single high IgM titer does not confirm active disease. A fourfold rise in paired IgG titers collected 2 to 4 weeks apart is more indicative of recent or reactivated infection. Serology alone cannot differentiate active tissue cyst rupture from latent infection.

Polymerase Chain Reaction (PCR)

PCR detection of T. gondii DNA in blood, aqueous humor, cerebrospinal fluid (CSF), bronchoalveolar lavage fluid, or tissue aspirates provides strong evidence of active infection. Real-time PCR assays targeting the B1 gene or 529 bp repeat element offer high sensitivity and specificity. Positive PCR in CSF is highly diagnostic for CNS toxoplasmosis.

Cytology and Histopathology

Cytology: Direct smears or impression smears of lymph node aspirates, CSF sediment, or bronchoalveolar lavage may reveal crescent-shaped tachyzoites (approximately 2 x 6 µm) extracellularly or within macrophages. Tachyzoites have a distinct nucleus and a pointed apical end. They stain basophilic with Romanowsky stains (Wright, Giemsa, Diff-Quik). Bradyzoites are rarely seen in cytological specimens unless a tissue cyst is ruptured. Cytological identification requires careful examination under oil immersion (1000x magnification) because tachyzoites can be mistaken for debris or other organisms.

Histopathology: Biopsy or necropsy specimens show multifocal necrosis and granulomatous inflammation. Immunohistochemistry using anti-Toxoplasma antibodies is the gold standard for confirming the presence of organisms in fixed tissue.

Imaging

Magnetic resonance imaging (MRI) of the brain may reveal multifocal, contrast-enhancing lesions in the cerebrum, cerebellum, or brainstem. These lesions are often T2-hyperintense with variable perilesional edema. Computed tomography (CT) is less sensitive but may show hypodense areas. Imaging findings are supportive but not pathognomonic.

Pregnancy Risks and Zoonotic Considerations

Risks in Pregnant Cats

Transplacental transmission during gestation carries significant risk to the litter. If a queen acquires primary infection during pregnancy (especially in the first trimester), the resulting kittens may be stillborn, die neonatally, or develop congenital toxoplasmosis with ocular or neurological deficits. Kittens that survive may harbor tissue cysts and suffer recrudescent disease later in life. Clinical signs in affected kittens include failure to thrive, tremors, seizures, and uveitis.

Veterinary management of a pregnant queen with suspected or confirmed toxoplasmosis involves careful diagnostic confirmation (serology, PCR) and limited use of medications that are potentially teratogenic. Clindamycin is the drug of choice during pregnancy, although its safety profile in the feline fetus is not fully established. Supportive care and monitoring for complications are critical. In cases of confirmed congenital infection in newborn kittens, prompt treatment with clindamycin may improve outcomes but cannot reverse existing damage.

Zoonotic Risk for Pregnant Humans

While this article focuses on feline medicine, a brief note on human risk is warranted for veterinary counseling. Pregnant women and immunocompromised individuals should avoid exposure to cat feces, especially during the oocyst shedding period (primary infection in the cat). Routine litter box cleaning by non-pregnant household members, use of gloves, and hand hygiene are effective precautions. Cats that are already seropositive (IgG positive) pose minimal risk because they are unlikely to shed oocysts again. The primary human infection route is ingestion of undercooked meat, not direct contact with cats.

Treatment and Prognosis

Antiprotozoal Therapy

Clindamycin hydrochloride is the first-line treatment for clinical toxoplasmosis in cats. The typical dosage is 12.5 to 25 mg/kg orally every 12 hours or 10 mg/kg intravenously for severe cases. Duration of therapy is 2 to 4 weeks, depending on clinical response. Adverse effects include vomiting, diarrhea, and rarely, pseudomembranous colitis.

Alternative or adjunctive therapies include:

• Trimethoprim-sulfonamide combinations (15 mg/kg trimethoprim, 75 mg/kg sulfonamide every 12 hours)
• Pyrimethamine (0.5 to 2 mg/kg daily) combined with a sulfonamide (caution: myelosuppressive, requires folinic acid supplementation)
• Azithromycin (7 to 15 mg/kg every 12 to 24 hours) for ocular cases

Corticosteroids (e.g., prednisolone at anti-inflammatory doses) are indicated in ocular and CNS toxoplasmosis to reduce inflammation and prevent immune-mediated damage. They should be used only in conjunction with antiprotozoal therapy.

Supportive Care

Cats with neurological signs may require anticonvulsants (e.g., levetiracetam for seizure management), nutritional support, and fluid therapy. Hospitalization is often required for severe cases. Serial neurological examinations help monitor treatment response.

Prognosis and Life Expectancy

The prognosis for cats with toxoplasmosis depends on the severity of initial infection and the timing of intervention. Cats with mild systemic signs generally recover fully with treatment. Those with CNS or ocular involvement have a guarded prognosis. In one retrospective study, approximately 30% of cats with neurological toxoplasmosis died or were euthanized despite treatment. Residual deficits (e.g., subtle ataxia, behavioral changes, blindness) are common in survivors.

Life expectancy after successful treatment is normal if no underlying immunosuppressive condition exists. The presence of concurrent retroviral infection (FeLV or FIV) worsens prognosis and may lead to recrudescence. Severe pulmonary or hepatic necrosis carries a higher acute mortality risk.

Prevention and Control

Preventing toxoplasmosis in cats hinges on reducing exposure to infected meat and oocysts.

• Feed only commercially processed cooked or canned cat food. Avoid raw meat diets.
• Prevent hunting and scavenging by keeping cats indoors.
• Clean litter boxes daily (oocysts require >24 hours to sporulate). Dispose of feces in sealed bags.
• Wear gloves when gardening and wash hands after handling soil.
• In breeding catteries, screen new arrivals by serology. Isolate seronegative queens from seropositive ones during pregnancy.

There is no commercial vaccine for toxoplasmosis in cats.

Diagnostic Workflow

The following Mermaid diagram summarizes a clinical decision algorithm for a cat presenting with neurological signs and suspected toxoplasmosis.

flowchart TD
    A[Cat with neurological signs], > B{Serology: IgM/IgG}
    B, >|IgM+ / IgG low| C[Acute infection likely]
    B, >|IgM+ / IgG+| D[Active or reactivated]
    B, >|IgM- / IgG+| E[Chronic infection]
    B, >|IgM- / IgG-| F[Consider other causes]
    C, > G[Perform PCR on CSF or blood]
    D, > G
    E, > H{Clinical signs consistent?}
    H, >|Yes| I[Perform CSF PCR and MRI]
    H, >|No| J[Monitor; no treatment]
    G, >|PCR positive| K[Treat with clindamycin]
    G, >|PCR negative| L[Re-evaluate differentials]
    I, >|MRI lesions + PCR+| K
    I, >|No lesions| L
    K, > M[Assess response in 7-14 days]
    M, >|Improvement| N[Continue treatment 14-28 days]
    M, >|Worsening| O[Re-evaluate, consider adjunctive therapy]
    N, > P[Monitor for recurrence]

References

[1] Dubey, J.P. Toxoplasmosis of Animals and Humans. 2nd ed., CRC Press, 2010.

[2] Lappin, M.R. "Toxoplasmosis." In: Greene, C.E. (ed.), Infectious Diseases of the Dog and Cat. 4th ed., Elsevier Saunders, 2012, pp. 730-744. (Note: No additional real citations were available; these references represent standard clinical textbooks used in veterinary parasitology and infectious disease practice.)